Brief: Theravance Biopharma Q1 Operating Income USD -11.207 Million
13/05/2024 21:05
May 13 (Reuters) - Theravance Biopharma Q1 adjusted net income USD -4.544 million vs. IBES estimate USD -12.5 million. * Q1 net income USD -11.664 million
Recent news on Theravance Biopharma
See all newsIreland's Theravance Biopharma Q1 revenue beats estimates on YUPELRI growth
Ireland's Theravance Biopharma Q4 revenue misses expectations
Corrected: BRIEF-Theravance Biopharma Q4 Operating Income USD 20.012 Million
U.S. STOCKS ON THE MOVE-Versant Media Group, Lithium miners, Expedia Group
U.S. STOCKS ON THE MOVE-Expedia Group, Blue Owl Capital, Enphase Energy